AstraZeneca Pays Texas $110M For Off-Label Marketing Of Seroquel, Crestor

(August 8, 2018, 1:23 PM EDT) -- AUSTIN, Texas — AstraZeneca LP has agreed to pay $110 to resolve two Texas state Medicaid fraud lawsuits for the wrongful promotion of the antipsychotic drug Seroquel and the statin drug Crestor, the Texas attorney general’s office announced Aug. 7 (State of Texas, ex. rel. Allison Zayas, et al. v. AstraZeneca, L.P., et al., No. D-1-GN-13-003530, State of Texas, ex rel. Layne D. Foote, et al. v. AstraZeneca, L.P., et al., No. D-1-GV-13-000812, Texas Dist., Travis Co.)....